CBA-88887-21699
4 vaccinations
8 coded responses
43 check-ins
7 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 857 / AZ
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
- 2021-03-30
-
2021-03-31
Survey response — days 1–6 daily, dose 1MedDRA: Injected limb mobility decreased, Injection site pain — Feeling: Good · Site: PainFree text: My whole upper arm around the injection site is sore with reduced range of motion due to pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 1MedDRA: Contusion, Injection site reaction — Feeling: Good · Site: RednessFree text: Mild bruising around injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
- 2021-04-20
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-04-23
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-07
-
2021-05-14
Survey response — day 21, dose 2MedDRA: Asthenia, Dyspnoea, Palpitations — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Shortness of breath, weakness, palpitationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-07-23
- 2021-10-22
-
2021-10-30
Dose 3 — Pfizer-BioNTech
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-13
-
2021-11-20
Survey response — day 21, dose 3MedDRA: Body temperature increased, Cough, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Unusual fatigue, cough, mildly elevated temperature (briefly)MedDRA releases: 2024-11 · check-in free text available
- 2021-11-27
- 2021-12-04
- 2021-12-11
-
2022-01-29
Survey response — 3 months, dose 3MedDRA: Breakthrough COVID-19, Cough, Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: I experienced significant symptoms of a breakthrough case of COVID-19 from 1/10/22-1/22/22 and still have some residual cough and fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-29
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-31
Call successfulParticipant prefers to complete VAERS report online
- 2022-04-30
-
2022-09-14
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-30
Survey response — 12 months, dose 3MedDRA: COVID-19, Dizziness, Fatigue — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fatigue, dizziness. If I check my daily mood/health logs, things have not improved on average since my last COVID infection early August 2022.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-30
Survey response — day 42, dose 4MedDRA: COVID-19, Dizziness, Fatigue — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fatigue, dizziness. I had a COVID infection August 2022 and things have not really improved since then.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-30
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-30
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-31
-
2022-10-31
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-12-14
-
2023-03-15
Survey response — 6 months, dose 4MedDRA: Affective disorder, Brain fog, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-15
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-16
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2021-10-30 | Pfizer-BioNTech | No |
| 4 | 2022-09-14 | Pfizer-BioNTech | Flu |
Call center
4 call center cases
4 successful
VAERS report filed, before or during a call: 1
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): My whole upper arm around the injection site is sore with reduced range of motion due to pain.
Systemic reaction (other): Mild bruising around injection site
Release 8 — day 21, dose 2
Symptoms: Shortness of breath, weakness, palpitations
Release 10 — day 21, dose 3
Symptoms: Unusual fatigue, cough, mildly elevated temperature (briefly)
Release 11 — 3 months, dose 3
Symptoms: I experienced significant symptoms of a breakthrough case of COVID-19 from 1/10/22-1/22/22 and still have some residual cough and fatigue.
Release 12 — day 42, dose 4
Symptoms: Fatigue, dizziness. I had a COVID infection August 2022 and things have not really improved since then.
Release 12 — 12 months, dose 3
Symptoms: Fatigue, dizziness. If I check my daily mood/health logs, things have not improved on average since my last COVID infection early August 2022.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Affective disorder | · | · | ✓ |
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Breakthrough COVID-19 | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Contusion | ✓ | ✓ | ✓ |
| SRO | Injected limb mobility decreased | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release